Prototype DAA/TAA Vaccine Targeting MUC1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Prototype DAA/TAA Vaccine Targeting MUC1, covering 2026-03-12 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ [Phase 1]